期刊文献+

分化抑制因子1对结肠癌HT-29细胞增殖的影响 被引量:6

Effect of Id1 on proliferation of colon cancer HT-29 cells
下载PDF
导出
摘要 目的检测分化抑制因子1(Id1)对结肠癌HT-29细胞VEGF表达的影响,探讨其在结肠癌增殖中的作用。方法 HT-29转染Id1表达质粒,RT-PCR方法和Western印迹法检测血管内皮生长因子(VEGF)mRNA和蛋白的表达,MTT法检测各组细胞增殖情况;合成Id-1干扰序列转染HT-29细胞后,RT-PCR及Western印迹检测HT-29细胞VEGF mRNA和蛋白的表达情况,采用MTT法检测各组细胞增殖情况。结果 Id1表达质粒空白组、对照组(空载体组)、过表达组VEGF/GAPDH mRNA分别为:0.002 99±0.000 687、0.003 49±0.001 34、0.031 3±0.006 05(P<0.01);VEGF/GAPDH蛋白分别为:0.132±0.035 1、0.131±0.053 0、0.245±0.032 6(P<0.01),MTT实验显示相对对照组,过表达组增殖明显快(P<0.01)。Id-1干扰空白组、对照组(空载体组)、抑表达组VEGF/GAPDH mRNA分别为:0.006 16±0.000 829、0.006 26±0.000 447、0.002 3±0.000 308(P<0.01);VEGF/GAPDH蛋白分别为:0.450±0.039 3、0.464±0.023 1、0.231±0.027 3(P<0.01)。MTT实验显示相对对照组,抑表达组增殖明显减慢(P<0.01)。Id1过表达能显著上调VEGF mRNA和蛋白表达,提高细胞的生长,Id1抑制后能显著下调VEGF mRNA和蛋白表达,减缓细胞的生长。结论在结肠癌HT-29细胞中Id1为VEGF的上游基因,Id1通过Id1↑→VEGF↑途径来影响结肠癌细胞增殖,在肿瘤血管生成中发挥重要作用。Id1有望成为结肠癌治疗的一个新靶点。 Objective To investigate the role of inhibitor of differentiation-I (ldl) on proliferation of colon cancer HT-29 cells by detecting the effect of Idl on the expression of vascular endothelial growth factor (VEGF) in hypoxia HT-29 cells. Methods The expression of VEGF mRNA and protein were detected by RT-PCR and Western blot assay in HT-29 cells after HT-29 cells transfeetion with Idl expressing plasmid. The proliferation of HT-29 cells was investigated by MTT methods after HT-29 cells transfection with Idl expressing plasmid. Results After transfection with ldl expressing plasmid, the VEGF/GAPDH mRNA expression of blank group, control group and over-ex- pression group detected by RT-PCR were 0. 002 99 ±0. 000 687, 0. 003 49±0. 001 34, 0. 031 3±0. 006 05( P 〈0. 01 ) , and VEOF/GAPDH protein expression were 0. 132±0. 035 1 , 0. 131±0. 053 0, 0. 245±0. 032 6 respectively ( P 〈 0. 01 ). MTT assay showed thai the cell proliferation of over-expression group was significantly faster than that of control group. After transfection with ldl-siRNA, the VEGF/GAPDH mRNA expression of blank group, control group and over-expression group were 0. 006 16±0. 000 829, 0. 006 26±0. 000 447,0. 002 3 ±0. 000 308 ( P 〈 0. 01 ) , and the VEGF/GAPDH protein were 0. 450± 0. 039 3, 0. 464±0. 023 1, 0. 231±0. 027 3 respectively ( P 〈 0. 01). MTT assay showed that the cell proliferation of over-expression group was significantly slower than that of control group. The over-expresssion of Idl could promote the expressions of both the mRNA and protein of VEGF and ldl suppression could significantly reduce the expressions of both the mRNA and protein of VEGF. Conclusions Idl can down-regulate the expression of VEGF in HT-29 cells and play an important role in colon cancer proliferation by Id1↑-VEGF↑ way. Idl is expected to become a new target for colon cancer therapy.
作者 于游 张才全
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第12期2829-2832,共4页 Chinese Journal of Gerontology
关键词 分化抑制因子1 结肠癌 HT-29细胞 增殖 血管内皮生长因子 Inhibitor of differentiation-1 Colon cancer HT-29 cells Proliferation VEGF
  • 相关文献

参考文献12

  • 1Ling MT, Wang X, Zhang X, et al. The multiple roles ol Id-1in cancerprogression[ J]. Differentiation,2006;74(9-10):481-7.
  • 2Kebebew E, Treseler PA, Duh QY, et al. The helix-loop-helixtransitrip-tion factor,Id-1,is overexpressed in medullary thyroid cancer [J]. Sur-gery,2000;128(6):952-7.
  • 3Wilson JW,Deed RW,Inoue T,ei al. Expression of Id elix-loop-helix pro-teins in colorectal adenocarcinoma correlates with p53 expression and mi-totic index[ J]. Cancer Res, 2001;61(24):8803-10.
  • 4曾达武,方明霞,刘豫瑞.RNA干扰分化抑制因子-1基因表达对食管鳞状细胞癌增殖与凋亡的影响[J].福建医科大学学报,2009,43(6):447-451. 被引量:5
  • 5Benezra R,Davis RL,Lockshon D,et al. The protein Id:a negative regulator of helix-loop-helix DNA binding proteins[ J]. Cell, 1990;61(1 ):49-59.
  • 6Yokota Y, Mori S. Role of Id family proteins in growth control[ J ]. J CellPhysiol,2002;190(1 ):21-8.
  • 7Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins incancer[ J]. Nat Rev Cancer,2005;5(8):603-14.
  • 8Lyden D, Young AZ,Zagzag D ,et al. Id1 and Id3 are required for neuro-genesis ,angiogenesis and vascularization of tumour xenografts [ J]. Na-ture, 1999;401(6754):670-7.
  • 9Ling MT,Wang XfOuyang XS,et al. Activation of MAPK signaling path-way is essential for Id-1 induced serum independent proslale cancer cellgrowth[ J]. Oncogene,2002;21(55):8498-509.
  • 10Folkman J. Tumor angiogenesis:the rapeutic implications[ J ]. N Eng J,1971;285(20):1182-6.

二级参考文献11

  • 1刘豫瑞,庄则豪,李友炳,黄雄飞,曾达武.ID-1、Ki-67及Bcl-2在食管鳞状细胞癌中的表达及意义[J].中华消化内镜杂志,2005,22(5):327-330. 被引量:10
  • 2Mariette C, Piessen G,Triboulet J P. Therapeutic strategies in esophageal carcinoma : role of surgery and other modalities[J]. Lancet Oncol , 2007,8(6) :544-553.
  • 3Hui C M,Cheung P Y,Ling M T, etal. Id-1 promotes proliferation of p53-deficient esophageal cancer cells[J]. Int J Cancer, 2006,119(3):508-514.
  • 4Lee T K,Poon R T,Yuen A P, etal. Regulation of angiogenesis by Id-1 through hypoxia-inducible factetor-la-mediated vascular endothelial growth factor up-regulation in hepatoeellular carcinoma[J].Clin Cancer Res , 2006,12(13) :6910-6919.
  • 5Bass B L. RNA intefrerence, the short answer[J]. Nature, 2001,411 (6836) :428-429.
  • 6Davidson B L, Boudreau R L. RNA interference: a tool for querying nervous system function and an emerging herapy[J]. Neuron, 2007 ,53 (6) : 781-788.
  • 7Wesetrhout E M, Berkhout B. A systematic analysis of the effect of target RNA structure on RNA inetfrerence[J]. Nucleic Acids Res, 2007,35 (13):4322-4330.
  • 8Li B,Cheung P Y,Wang X, et al. Id-1 activation of PISK/ Akt/NF-kappa B signaling pathway and its significance in promoting survival of esophageal cancer cells[J]. Carcinogenesis J T- Carcinogenesis, 2007,28(11) ,2313-2320.
  • 9Swarbrick A, Akerfeldt M C, Lee C S, et al. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix loop helix protein Id-1[J]. Oncogene, 2005, 24(3) :381-389.
  • 10Zhang X M,Ling M T,Wang Q, ct al. Identification of a novel inhibitor of differentiation-1 binding partner, eaveolin-1, and its role in epithelial-mesenchymal transitionand resistance to apoptosis in prostate cancer cells[J].J Boil Chem, 2007, 282(46) :33284-33294.

共引文献4

同被引文献85

  • 1樊鸿炎,张文权,薛迪强,杜宏伟,郝芳,李素萍.DNA结合抑制蛋白-1在结肠癌中的表达及其临床意义[J].中国老年学杂志,2014,34(2):320-322. 被引量:1
  • 2李晓军,秦浚川.细胞分化抑制因子(Id)研究进展[J].生物化学与生物物理进展,2004,31(10):865-869. 被引量:29
  • 3Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J ]. Int J Cancer, 2010, 127 (12) :2893-2917.
  • 4Horn L, Sandier AB. Angiogenesis in the treatment of non-small cell lung cacer [J]. Proc Am Thorac Sco, 2009,6(2) :206-217.
  • 5Zagzay D. Angiogenic growth factors in neural emnryogenesis and neoplasia[ J]. Am J Pathol, 1999,146(2) :293-309.
  • 6Cavallaro U, Tenan M, Castelli V, et al. Response of bovine en- dothelial cells to FGF-2 and VEGF is dependent on their site of ori- gin: relevance to the regulation of angiogenesis [ J ]. J Cell Bio- chem, 2001,82(4) :619-633.
  • 7Yang L, Lin Z, Huang Q, et al. Effect of vascular endothelial growth factor on remodeling of C6 glioma tissue in vivo[ J]. J Neu- rooncology, 2011,103 ( 1 ) :33-41.
  • 8Brock AA, Ranganathan S, Abounader R, et al. Scatter factor/ hepatocyte growth factor gene transfer increases rat blood glioma barrier permeability [ J ]. Brain Res, 1999,833 ( 2 ) : 173-180.
  • 9da Silva L, Neves BM, Moura L, et al. Neurotensin downregulates the pro-inflammatory properties of skin dendritic cells and increases epidermal growth factor expression [ J ]. Biochim Biophys Acta, 2011.1813(10) ,1863-1871.
  • 10Feletou M, Staczek J, Duhault J, et al. Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch[J]. Br J Pharmacol, 2001,132(6) :1342-1348.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部